F3 - Stimulant-Focused Contingency Management in Opioid Treatment Programs: Barriers to Implementation and Policy Implications

Wednesday, May 22, 2024

10:00 AM – 11:30 AM PST

Location: Celebrity 1-4

CE: 1.5

Primary Presenter(s)

K. Michelle Peavy, PhD, MAC, SUDP

Associate Professor & Director of Training
Elson S. Floyd College of Medicine, Washington State University
Seattle, Washington

Download Slides

Co-Presenter(s)

Sara Parent, ND (she/her/hers)

Assistant Professor
Elson S. Floyd College of Medicine, Washington State University
Spokane, Washington
Lora Weed, PhDc, MA, LMHC, MHP, SUDP, CMHS (they/them/theirs)

Acting State Opioid Response Grant Director
American Psychiatric Association (APA), National Alliance on Mental Illness (NAMI)
Olympia, Washington

Presentation Summary: Contingency management (CM) is a behavioral intervention with demonstrated efficacy in helping people reduce or cease stimulant use. Despite its research base with individuals enrolled in Opioid Treatment Programs (OTPs), the intervention is underused due to OTP-specific and more general implementation barriers. In this presentation, we discuss a stimulant-focused CM implementation pilot across Washington State opioid treatment settings. We review our training and technical assistance efforts, implementation data, and lesson learned. Based on our experience, we provide recommendations for individual sites interested in implementation of stimulant-focused CM, and discuss policy implications more broadly.

Learning Objectives:

At the completion of this activity, participants will:

Describe an evidence-based Contingency Management protocol focused on stimulant abstinence that has been piloted across Washington State opioid treatment settings.
List barriers to successful implementation of stimulant-focused Contingency Management protocols in Opioid Treatment Program settings.
Discuss potential policy changes that could reduce CM implementation barriers in Opioid Treatment Programs.